Levels of blood periostin decrease after acute myocardial infarction and are negatively associated with ventricular function after 3 months

Journal of Investigative Medicine

Volumn 60, Issue 2, 2012, Pages 523-528

  Cheng, Chi Wen ^a,b   Wang, Chao Hung ^a,b   Lee, Ju Fang ^a,b   Kuo, Li Tang ^a,b   Cherng, Wen Jin ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Acute myocardial infarction; Brain natriuretic peptide; Outcome; Periostin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TRANSCRIPTION FACTOR RUNX2;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 84863037830     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182408549     Document Type: Article

References (24)

1. Mikhail GW. Coronary revascularisation in women. Heart. 2006;92(suppl 3):iii19-iii23.
2. Bicknell KA, Coxon CH, Brooks G. Can the cardiomyocyte cell cycle be reprogrammed? J Mol Cell Cardiol. 2007;42(4):706-721. (Pubitemid 46527595)
3. Leontiadis E, Manginas A, Cokkinos DV. Cardiac repairVfact or fancy? Heart Fail Rev. 2006;11(2):155-170.
4. Kühn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13(8):962-969. (Pubitemid 47222046)
5. Litvin J, Blagg A, Mu A, et al. Periostin and periostin-like factor in the human heart: possible therapeutic targets. Cardiovasc Pathol. 2006;15(1):24-32. (Pubitemid 43088767)
6. Shimazaki M, Nakamura K, Kii I, et al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med. 2008;205(2): 295-303. (Pubitemid 351281595)
7. Dorn GW 2nd. Periostin and myocardial repair, regeneration, and recovery. N Engl J Med. 2007;357(15):1552-1554.
8. Oka T, Xu J, Kaiser RA, et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007;101(3):313-321. (Pubitemid 47351119)
9. Iekushi K, Taniyama Y, Azuma J, et al. Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension. 2007;49(6): 1409-1414. (Pubitemid 46809387)
10. Katsuragi N, Morishita R, Nakamura N, et al. Periostin as a novel factor responsible for ventricular dilation. Circulation. 2004;110(13):1806-1813. (Pubitemid 39299222)
11. Fisher C, Berry C, Blue L, et al. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart. 2003; 89(8):879-881. (Pubitemid 36920811)
12. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106(23):2913-2918. (Pubitemid 35424741)
13. Kragelund C, Gronning B, Kober L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005;352(7):666-675. (Pubitemid 40239214)
14. Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14(7): 1239-1249. (Pubitemid 29314070)
15. Li G, Oparil S, Sanders JM, et al. Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis. 2006;188(2):292-300. (Pubitemid 44301134)
16. Ouyang G, Liu M, Ruan K, et al. Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett. 2009;281(2):213-219.
17. Djurovic S, Thelle DS, Ringstad J, et al. Altered serum concentrations of TGF-beta 1 and Lp(a) lipoprotein and their correlation in patients with first acute myocardial infarction. Nutr Metab Cardiovasc Dis. 1999;9(5):250-254. (Pubitemid 129634426)
18. Kempf K, Haltern G, Futh R, et al. Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction. Horm Metab Res. 2006;38(5):346-351. (Pubitemid 43864958)
19. Tahara A, Yasuda M, Itagane H, et al. Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease. Am Heart J. 1991;122(4 Pt 1):986-992.
20. Snider P, Standley KN, Wang J, et al. Origin of cardiac fibroblasts and the role of periostin. Circ Res. 2009;105(10):934-947.
21. Banerjee I, Fuseler JW, Intwala AR, et al. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. Am J Physiol Heart Circ Physiol. 2009;296(5):H1694-H1704.
22. Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab. 2000; 71(1-2):418-435.
23. Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking preventsmyocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation. 2002;106(1):130-135. (Pubitemid 34747453)
24. Lim H, Zhu YZ. Role of transforming growth factor-beta in the progression of heart failure. Cell Mol Life Sci. 2006;63(22): 2584-2596. (Pubitemid 44800713)